NASDAQ · CRBP

Corbus Pharmaceuticals Holdings, Inc.

Closing price · Nov 13, 2026 $3.39

Last insider buy · Aug 11, 2026 $9.63

Latest quarter · ended Sep 30, 2026

Cash got weaker

descriptionFiled Nov 10, 2026

Cash from operationsWorse

−$21.2M

Dec '24Sep '26

vs. −$15.6M a year ago

Share countDiluting

+17.4%

Dec '24Sep '26

20.61M shares vs. 17.55M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Selling Insiders: as of Nov 13 Funds: as of Jun 30, 2026

account_balance
4 funds bought, 4 sold in the quarter ended Jun 30, 2026, counting funds that hold 500 stocks or fewer and $1M+ of this one. Index funds and banks are left out.
info
5 real insider sales in 12 months. $1.85M in total, not counting planned sales.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

110 funds report owning CRBP, up from 106

Holdings as of Jun 30, 2026

New28

Added29

Held29

Trimmed24

Sold out24

Last quarter

Who bought and who sold

Apr–Jun 2026

Prosight Management, LP

−7%

Jones Hill Capital LP

New

Diadema Partners LP

−32%

Stonepine Capital Management, LLC

+11%

Adar1 Capital Management, LLC

+27%

Armistice Capital, LLC

Sold

Exome Asset Management LLC

−21%

Dafna Capital Management LLC

New

Change in shares held from Mar 31 to Jun 30, 2026, biggest holdings first. Only funds that hold 500 stocks or fewer and $1M+ of this one: index funds and banks own almost everything, so their changes say little. Bars stop at ±100%.

Insider trades · last 12 months

Real buys and sales

● Open-market buy● Open-market sale

Last 6 months. A wider screen shows 12.

Showing 8 real trades. Hidden: 12 stock grants, 8 planned 10b5-1 sales. Those happen on a schedule and say little about what an insider thinks. Bigger dot means a bigger trade.

Real trades, newest first

Oct 29 Cormorant Asset Management, LP Officer Open-market sale $1.74M 425,000 sh at $4.10 Sold 18% of stake

Aug 11 Nishant Saxena Chief Business Officer Open-market buy $25K 2,600 sh at $9.63

Jun 3 Nishant Saxena Chief Business Officer Open-market buy $68.2K 9,000 sh at $7.58

Jun 2 Nishant Saxena Chief Business Officer Open-market buy $33K 4,500 sh at $7.33

Mar 2 Dominic Smethurst Chief Medical Officer Open-market sale $50.6K 6,097 sh at $8.30 Sold 6% of stake

Feb 17 Ian Hodgson COO Open-market sale $6.25K 847 sh at $7.38 Sold 2% of stake

Feb 3 Dominic Smethurst Chief Medical Officer Open-market sale $26.6K 3,285 sh at $8.09 Sold 3% of stake

Feb 3 Ian Hodgson COO Open-market sale $19.5K 2,415 sh at $8.09 Sold 4% of stake

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Top holders

Biggest funds in CRBP

As of Jun 30, 2026

Fund	Owns	Value	Change
Cormorant Asset Management, LP	11.4%	$22M	Same
Orbimed Advisors LLC	8.4%	$16.3M	Same
BlackRock, Inc.	6.5%	$12.5M	+390%
Aberdeen Group PLC	6.4%	$12.4M	Same
Vanguard Capital Management LLC	3.7%	$7.14M	+4%

"Owns" is shares reported divided by shares outstanding.